What is the investment case, and what must be true for it to hold?
NanoXplore's investment case is a commercialization bet: its graphene applications must move from customer qualification into actual orders while execution depends on clearing customer adoption steps. FY2026 total revenues were C$117.3 million, down 9% from C$128.9 million in the prior year. The Techmer PM plastic-film masterbatch partnership is progressing through customer qualification, with graphene orders for the masterbatch anticipated to begin during the second half of fiscal 2027.
The anticipated CP Chem customer opportunity for NanoSlide did not proceed after CP Chem lost a major customer for customer-specific commercial considerations unrelated to NanoSlide's performance. Well trials are the next phase of NanoSlide customer evaluation and the key determinant for advancing toward commercial adoption.
2Risk Factors
Which risks could break the thesis, and what would warn of them?
A customer-specific commercial setback can delay NanoXplore's shipments: the anticipated CP Chem opportunity did not proceed after CP Chem lost a major customer for reasons specific to that customer and unrelated to NanoSlide's performance, so further product shipments now depend on CP Chem's broader prospective customer base completing qualification and adoption, and the next evaluation phase turns on well trials as the key determinant of commercial adoption.
NanoXplore reported FY2026 total revenues of $117,276,309, a 9% decrease from the prior year.
NanoXplore
NanoXplore is a graphene powder and masterbatch manufacturer producing composites for the transportation, electronics, packaging and energy storage markets.